News Summary

The development of vaccines for hantavirus is progressing with several global initiatives. Moderna, a US-based biotechnology company, is collaborating with the Vaccine Innovation Center of Korea University College of Medicine on an mRNA-based hantavirus vaccine. This partnership aims to create a broad-spectrum immunization effective against multiple variants of the virus. Meanwhile, researchers at the University of Bath are also working on a promising new hantavirus vaccine. These efforts highlight the growing global focus on preventing hantavirus infections, which can cause serious diseases and have a high fatality rate.